936 related articles for article (PubMed ID: 32352397)
1. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
2. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
[TBL] [Abstract][Full Text] [Related]
3. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
[TBL] [Abstract][Full Text] [Related]
4. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.
Liu S; Luo H; Wang Y; Cuevas LE; Wang D; Ju S; Yang Y
BMC Infect Dis; 2020 Aug; 20(1):584. PubMed ID: 32762665
[TBL] [Abstract][Full Text] [Related]
6. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
Liu C; Li L; Song K; Zhan ZY; Yao Y; Gong H; Chen Y; Wang Q; Dong X; Xie Z; Ou CQ; Hu Q; Song Q
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32895296
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.
Wang H; Zhang Y; Mo P; Liu J; Wang H; Wang F; Zhao Q
Int Immunopharmacol; 2020 Aug; 85():106683. PubMed ID: 32531713
[TBL] [Abstract][Full Text] [Related]
10. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
Ji D; Zhang D; Xu J; Chen Z; Yang T; Zhao P; Chen G; Cheng G; Wang Y; Bi J; Tan L; Lau G; Qin E
Clin Infect Dis; 2020 Sep; 71(6):1393-1399. PubMed ID: 32271369
[TBL] [Abstract][Full Text] [Related]
11. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.
Gong J; Ou J; Qiu X; Jie Y; Chen Y; Yuan L; Cao J; Tan M; Xu W; Zheng F; Shi Y; Hu B
Clin Infect Dis; 2020 Jul; 71(15):833-840. PubMed ID: 32296824
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.
Sun S; Cai X; Wang H; He G; Lin Y; Lu B; Chen C; Pan Y; Hu X
Clin Chim Acta; 2020 Aug; 507():174-180. PubMed ID: 32339487
[TBL] [Abstract][Full Text] [Related]
13. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
15. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
[TBL] [Abstract][Full Text] [Related]
16. Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
Qin ZJ; Liu L; Sun Q; Li X; Luo JF; Liu JS; Liu D
Medicine (Baltimore); 2020 Aug; 99(35):e21700. PubMed ID: 32871887
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.
Xiao LS; Zhang WF; Gong MC; Zhang YP; Chen LY; Zhu HB; Hu CY; Kang P; Liu L; Zhu H
EBioMedicine; 2020 Jul; 57():102880. PubMed ID: 32645614
[TBL] [Abstract][Full Text] [Related]
18. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
Liu G; Zhang S; Hu H; Liu T; Huang J
Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
20. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]